Health and Medicine

August 30, 2012

Conte Center receives grant to study serotonin

The Silvio O. Conte Center for Neuroscience Research at Vanderbilt has received a $10.5 million federal grant to continue its groundbreaking research on serotonin signaling in the brain for another five years.

By Bill Snyder
August 30, 2012

Vanderbilt-led study reveals racial disparities in prostate cancer care

Racial differences exist in quality surgical care, new research from VICC finds.

By VUMC News and Communications
August 30, 2012

Targeting new pathways to ease pain

The spinal cord’s neuropeptide Y signaling pathway may be a good target for new pain therapeutics.

By Leigh MacMillan
August 28, 2012

Clues to retinal cell degeneration

A reversible chemical modification of rhodopsin, a receptor for light, plays a role in the degeneration of retinal cells.

By Leigh MacMillan
puzzel pieces, autism
August 27, 2012

Little evidence supports autism treatment options in adolescents

There is insufficient evidence to support findings, good or bad, for therapies currently used in adolescents and young adults with autism.

By VUMC News and Communications
August 24, 2012

Tool helps plumb electronic records

A tool developed for one institution’s electronic health records can work at other institutions, potentially facilitating the use of these records in research studies.

By VUMC News and Communications
August 23, 2012

VU, Lipscomb partner on dual degree program

A new cooperative program between Vanderbilt University and Lipscomb University’s College of Pharmacy is focusing on the next generation of pharmaceutical researchers. By offering a pathway for students to earn both Pharm.D. and Ph.D. degrees, the program aims to boost the number of pharmacy-trained research scientists.
By Leigh MacMillan
August 23, 2012

Gene linked to familial prostate cancer

A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows.
By VUMC News and Communications
August 16, 2012

Method may refine personalized trials for cancer therapy

A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy, and may offer a way to further refine personalized cancer treatments.
By VUMC News and Communications
August 16, 2012

African ancestry, stomach bug link

Socioeconomic factors, African ancestry linked to risk for cancer-causing infection.
By VUMC News and Communications
August 14, 2012

Flu Tool guides patient decision-making

Studies of Flu Tool, a computer application that guides health care decision-making, suggests that patients are willing to use these types of resources.
By Leigh MacMillan
August 10, 2012

Key to a woman’s heart (condition)?

Females may be at higher risk of potentially fatal heart condition due to gender differences in a protein involved in the heart’s electrical activity.
By VUMC News and Communications
August 9, 2012

New therapeutic target for cold, flu viruses identified

Viruses that cause acute respiratory infections — such as human metapneumovirus (HMPV) and flu — impair a set of immune system cells that should clear the virus from the lungs. Now, Vanderbilt University investigators have discovered the signaling pathway that disables these immune cells.
By Leigh MacMillan
1 … 162 163 164 165 166 … 192